Descrição
⋅ PS: I am a beginner. This is just my opinion. Only trade based on your analysis
-Glenmark announced the DCGI nod for selling of Fabiflu - Covid-19 med.
-Strong support between 390 and 400 (very strong at 394)
- Closed in its S/R zone of 408-415. If breakout above 418, can go till 432-437.
-Result on 26th June. Expected a positive result.
- If fall below 390, support placed at 380 and 370